Literature DB >> 9385738

The uncertain role of immunosuppressive agents in Sjögren's syndrome.

G Linardaki1, H M Moutsopoulos.   

Abstract

Although Sjögren's syndrome is an autoimmune disorder, immunosuppressive agents have yielded disappointing results in clinical trials. In this paper we summarize our experience using immunosuppressive and cytotoxic agents to treat Sjögren's syndrome, and present an illustrative case history.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9385738     DOI： 10.3949/ccjm.64.10.523

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  5 in total

Review 1.  Therapy of Sjögren's syndrome.

Authors:  N M Moutsopoulos; H M Moutsopoulos
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  Conventional therapy of Sjogren's syndrome.

Authors:  Clio P Mavragani; Haralampos M Moutsopoulos
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 3.  [Current therapeutic options in Sjögren's syndrome].

Authors:  A Hansen; T Dörner
Journal:  Z Rheumatol       Date:  2010-02       Impact factor: 1.372

Review 4.  Rational drug therapy recommendations for the treatment of patients with Sjögren's syndrome.

Authors:  P Oxholm; J U Prause; M Schiødt
Journal:  Drugs       Date:  1998-09       Impact factor: 9.546

5.  Treating Sjögren's Syndrome: Insights for the Clinician.

Authors:  Claudio Vitali; Gianluigi Palombi; Pierluigi Cataleta
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-06       Impact factor: 5.346
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.